CAMLINFINE - Camlin Fine Sciences

Camlin Fine Sciences

CAMLINFINE · Chemicals > Chemicals · Chairman: Ashish Dandekar · MD: Ashish Dandekar · Listing date: Jan. 20, 2015 · Employees: 430 · Mumbai · http://www.camlinfs.com

Stock Price vs Company Growth

13.5%

9.2%

3.8%

27.1%

45.8%

44.6%

7.6%

10y

6.2%

all

6.4%

🤔 How to analyze this graph?

Last Traded Price

₹ 164 13.5%

139

234

Company Overview

Sales

1,754 Cr

Growth: 7.7%

Profit after Tax

-29.2 Cr

Growth: -74.6%

Small Cap

3,148 Cr

P/E: 409.8x

Industry P/E: 25.4x

Fundamentals

Sales (Cr)	₹ 1,754
Growth	7.7%
EBITDA	9.2%
P/S	1.8x
Dividend	0.0%
P/E	409.8x
Book Value	₹ 45.7
PEG Ratio	53.3x
ROE	-3.4%
P/B	3.6x

Shareholding Pattern

Institutions

Icici Prudential Midcap Fund

8.62 %

Sbi Flexicap Fund

7.93 %

Infinity Direct Holding

4.82 %

Nirmal Vinod Momaya

2.82 %

Kuwait Investment Authority Fund 225

1.99 %

Promoters

Ashish Subhash Dandekar

11.02 %

Camart Industries Ltd

4.17 %

Vibha Agencies Pvt Ltd

2.04 %

Anagha Subhash Dandekar

1.19 %

Cafco Consultants Limited

1.17 %

Others

Increase Decrease No change

Company Profile Detailed

Camlin, the corporate group, was established in 1931 and is a pioneer in art and stationery material in India. Camlin diversified into Pharmaceuticals and Fine Chemicals two decades ago. The Fine Chemical Division of Camlin got de-merged into a separate company named as Camlin Fine Chemicals on 22nd December 2006. The entire management team and employees of Camlin Fine Chemicals Division are now a part of the independent legal entity formed under the Indian Companies Act 1956.

Belongs to (8 Indices) view more

Investors (97)

visa.cap...

ntgi.col...

sbi.magn...

Followers (7)

sudheer....

ratnesh2

indrajee...